AI funding rounds led by Singular
Singular led or co-led 3 funding rounds at 3 AI companies on Presspool's record, announced between September 30, 2026 and November 12, 2026. The most recent: Orakl Oncology, Sumary and Restate.
| Company | Amount | Round | Announced | Co-leads |
|---|---|---|---|---|
| Orakl Oncology | $34 million | Series A | November 12, 2026 | Norrsken VC |
| Sumary | $25m | Seed | November 9, 2026 | None named |
| Restate | $20 million | Series A | September 30, 2026 | None named |
Rounds by year
| Year | Rounds led | Total led, in dollars | Round types led |
|---|---|---|---|
| 2026 | 3 | $79 million | Series A (2), Seed |
Co-investors
Investors named with Singular on the rounds above: Capital One Ventures and Norrsken VC.
Each round and its sources
Orakl Oncology: $34 million Series A
Sumary: $25m Seed
Restate: $20 million Series A
What this page covers
Presspool records the lead investors of each round, as the company's announcement or the confirming outlets name them, and the other investors the round's entry names. This page lists the rounds this investor led on Presspool's record: every weekly AI startup funding roster, and the latest round of each company on a niche map. A round it joined without leading is listed when the round's entry names it, matched only to firms the record names as some round's lead. It is not the investor's full portfolio: rounds its sources did not name it in are not listed.